Antisense mediated exon skipping therapy for duchenne muscular dystrophy (DMD)
about
Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension StudyElectroporation Enhanced Effect of Dystrophin Splice Switching PNA Oligomers in Normal and Dystrophic Muscle.Peptide nucleic acids: a review on recent patents and technology transfer.Selection and Identification of Skeletal-Muscle-Targeted RNA Aptamers.
P2860
Antisense mediated exon skipping therapy for duchenne muscular dystrophy (DMD)
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Antisense mediated exon skipping therapy for duchenne muscular dystrophy (DMD)
@en
Antisense mediated exon skipping therapy for duchenne muscular dystrophy
@nl
type
label
Antisense mediated exon skipping therapy for duchenne muscular dystrophy (DMD)
@en
Antisense mediated exon skipping therapy for duchenne muscular dystrophy
@nl
prefLabel
Antisense mediated exon skipping therapy for duchenne muscular dystrophy (DMD)
@en
Antisense mediated exon skipping therapy for duchenne muscular dystrophy
@nl
P2860
P356
P1476
Antisense mediated exon skipping therapy for duchenne muscular dystrophy (DMD)
@en
P2093
Camilla Brolin
Takehiko Shiraishi
P2860
P356
10.4161/ADNA.2.1.15425
P577
2011-01-01T00:00:00Z